Terumo Corporation
4543.T
Below: live stock price for Terumo Corporation (4543.T), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.
Terumo Corporation (4543.T) is a Healthcare company based in Japan. Its primary business is Medical Devices. Over the past year 4543.T traded between 1,900 and 2,689 JPY. Trailing P/E sits near 21.57 on a market cap of about 3.55T JPY. It currently yields 1.50% in dividends.
- Prev close
- $15.04
- Volume (24h)
- $69.43M
- Market cap
- $22.52B
- Currency
- USD (native JPY)
Score
58/ 100 · Mixed
- Value55
- Quality59
- Momentum30
- Growth78
- Risk71
- Dividend56
- Liquidity56
Composite of public market data. Informational only — not investment advice.
Trend projection
Where the recent trend points if it continues.
- +5 bars
- 15.1874 -0.52%
- +20 bars
- 15.0779 -1.24%
- +60 bars
- 15.0358 -1.52%
- +120 bars
- 15.0343 -1.53%
Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: 1σ ≈ ±2.1% per bar.
Interpretation
Composite signals look mixed. Strength: growth with weakness: momentum. Price sits in the middle of the recent range, trend is sloping downward.
Descriptive observation — not investment advice.
Score breakdown
Raw values behind each pillar so you can see what the composite is reading.
- Value55/100
Value looks mixed — driven by P/E (21.57).
P/E:21.57P/B:2.13PEG:2.18 - Quality59/100
Quality looks mixed — driven by Gross margin (53.22%).
ROE:10.85%ROA:6.92%Profit margin:13.90%Gross margin:53.22% - Momentum30/100
Momentum looks weak — driven by 52w change (-4.39%).
52w change:-4.39% - Growth78/100
Growth looks strong — driven by Earnings growth (68.30%).
Revenue growth:19.90%Earnings growth:68.30% - Risk71/100
Risk looks solid — driven by Debt / equity (26.36).
Beta:0.31Debt / equity:26.36 - Dividend56/100
Dividend looks mixed — driven by Payout ratio (26.91%).
Dividend yield:1.50%Payout ratio:26.91% - Liquidity56/100
Liquidity looks mixed — driven by Current ratio (2.19).
Current ratio:2.19Quick ratio:1.31
Derived from public market data — informational, not investment advice.
Price report
How this asset has actually moved over the last 243 days.
Where the price sits between the window low and high.
- Volatility (annualised)
- 33.9%
- Max drawdown
- -25.0%
- Below period high
- -10.6%
- Best day
- +18.57%
- Worst day
- -6.27%
- Up days
- 51%
- Current streak
- 2 up
- Typical day swing
- 2.4%
- Volume vs average
- +16%
Spread of returns. Higher means larger swings in both directions.
Worst peak-to-trough fall inside the window.
Current price against the highest point in the window.
Share of days that closed above the one before.
Average high-to-low spread within a single day.
Last 10 days against the whole window.
Descriptive statistics over past prices — not a forecast and not investment advice.
Reference levels
Fibonacci retracements and extensions across the recent range.
Reference only — not investment advice.
These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.
Levels derived from: 17.0736 high → 13.9338 low · 60 bars
- ResistanceFib +161.8% extensionnot reached22.1538 USD+45.11% from current
- ResistanceFib +100% extensionnot reached20.2134 USD+32.40% from current
- ResistanceFib +61.8% extensionnot reached19.014 USD+24.54% from current
- ResistanceFib +27.2% extensionnot reached17.9277 USD+17.43% from current
- ResistanceFib 23.6% retracementtested 10×16.3326 USD+6.98% from current
- ResistanceFib 38.2% retracementtested 3×15.8742 USD+3.98% from current
- ResistanceFib 50% midpointtested 6×15.5037 USD+1.55% from current
- Current15.2672 USD
- SupportFib 61.8% retracementNearesttested 6×15.1332 USD-0.88% from current
- SupportFib 78.6% retracementtested 19×14.6057 USD-4.33% from current
- SupportFib −27.2% extensionnot reached13.0798 USD-14.33% from current
- SupportFib −61.8% extensionnot reached11.9934 USD-21.44% from current
- SupportFib −100% extensionnot reached10.794 USD-29.30% from current
How to read this
We take the highest and lowest price of the last 60 bars and cut the gap between them at the classic Fibonacci ratios (23.6%, 38.2%, 50%, 61.8%, 78.6%), plus extensions beyond both ends.
“Tested N×” counts how many of those 60 bars actually traded through the level. A level price has crossed many times is one the market has repeatedly agreed on; a level at 0 is pure geometry the price has never reached.
This is a map of where trading has already happened — not a forecast and not a signal. Price moves through these levels all the time.
Financials
- 52w high
- ¥2,689
- 52w low
- ¥1,900
- 52w change
- -4.39%
- Day high
- ¥2,427.5
- Day low
- ¥2,351
- P/E (TTM)
- 21.57
- Forward P/E
- 23.61
- PEG
- 2.18
- Price / Book
- 2.13
- Beta (5Y)
- 0.31
- Enterprise value
- 3.67T
- EV / Revenue
- 3.1
- EV / EBITDA
- 12.01
- EPS (TTM)
- ¥111.49
- Forward EPS
- ¥101.83
- Dividend yield
- 1.50%
- Dividend rate
- ¥36
- Payout ratio
- 26.91%
- Revenue (TTM)
- 1.18T
- EBITDA
- 305.71B
- Free cash flow
- 95.83B
- Total cash
- 314.63B
- Total debt
- 438.06B
- Debt / Equity
- 26.36
- Current ratio
- 2.19
- Quick ratio
- 1.31
- Profit margin
- 13.90%
- Gross margin
- 53.22%
- Return on assets
- 6.92%
- Return on equity
- 10.85%
- Shares outstanding
- 1.48B
- Float
- 1.45B
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular stent grafts, and others. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The Terumo Organ Technologies segment provides organ preservation devices. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Shibuya, Japan.
Analyst & Risk
Analysts' consensus via Yahoo Finance — not investment advice.
- Beta (vs S&P 500)
- 0.31
- very stable
- 52-week change
- -4.39%
- Debt / Equity
- 26.36
- very high leverage
- Current ratio
- 2.19
- Quick ratio
- 1.31
- ROE
- 10.85%
- ROA
- 6.92%
- PEG ratio
- 2.18
- EV / Revenue
- 3.1
- EV / EBITDA
- 12.01
- Revenue growth
- 19.90%
- Earnings growth
- 68.30%
- EBITDA
- 305.71B
- Free cash flow
- 95.83B
- Total cash
- 314.63B
- Total debt
- 438.06B
- Insider holdings
- 2.29%
- Institutional
- 68.07%
Related
Other assets in this category.
Learn the terms
Live discussion
Sign in to join the discussion.
- No comments yet. Be the first.